These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12422060)

  • 21. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population.
    Kishi T; Fukuo Y; Yoshimura R; Okochi T; Kitajima T; Naitoh H; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    Hum Psychopharmacol; 2010 Aug; 25(6):481-6. PubMed ID: 20737521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.
    Yoshida K; Higuchi H; Kamata M; Takahashi H; Inoue K; Suzuki T; Itoh K; Ozaki N
    J Psychopharmacol; 2007 Aug; 21(6):650-6. PubMed ID: 17092970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the A-1438G polymorphism in serotonin 2A receptor in migraine with aura among Japanese patients.
    Naito Y; Ishii M; Nagamine A; Imagawa A; Shida K; Takahashi J; Hosaka Y; Naito Y; Oyamada H; Shimizu S; Oguchi K; Hara H; Masuda Y; Usami S; Kiuchi Y
    Biol Pharm Bull; 2010; 33(10):1751-3. PubMed ID: 20930387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis.
    Rausch JL; Hobby HM; Shendarkar N; Johnson ME; Li J
    J Clin Psychopharmacol; 2001 Apr; 21(2):139-42. PubMed ID: 11270909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine.
    Ito K; Yoshida K; Sato K; Takahashi H; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Psychiatry Res; 2002 Aug; 111(2-3):235-9. PubMed ID: 12374640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
    Illi A; Setälä-Soikkeli E; Viikki M; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E; Kampman O
    Neuroreport; 2009 Aug; 20(12):1125-8. PubMed ID: 19590397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?
    Kertzman S; Vainder M; Reznik I; Gotzlav Y; Weizman A; Kotler M; Iancu I
    Int Clin Psychopharmacol; 2012 May; 27(3):134-41. PubMed ID: 22415223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
    Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.
    Katoh Y; Uchida S; Kawai M; Takei N; Mori N; Kawakami J; Kagawa Y; Yamada S; Namiki N; Hashimoto H
    Biol Pharm Bull; 2010; 33(12):1999-2002. PubMed ID: 21139240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased abdominal obesity in subjects with a mutation in the 5-HT(2A) receptor gene promoter.
    Rosmond R; Bouchard C; Björntorp P
    Ann N Y Acad Sci; 2002 Jun; 967():571-5. PubMed ID: 12079891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.
    Fukuo Y; Kishi T; Kushima I; Yoshimura R; Okochi T; Kitajima T; Matsunaga S; Kawashima K; Umene-Nakano W; Naitoh H; Inada T; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2011 Sep; 133(1-2):150-7. PubMed ID: 21663972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A.
    Enoch MA; Goldman D; Barnett R; Sher L; Mazzanti CM; Rosenthal NE
    Mol Psychiatry; 1999 Jan; 4(1):89-92. PubMed ID: 10089016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders.
    Walitza S; Wewetzer C; Warnke A; Gerlach M; Geller F; Gerber G; Görg T; Herpertz-Dahlmann B; Schulz E; Remschmidt H; Hebebrand J; Hinney A
    Mol Psychiatry; 2002; 7(10):1054-7. PubMed ID: 12476319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT2A receptor gene promoter polymorphism -1438A/G and bipolar disorder.
    Chee IS; Lee SW; Kim JL; Wang SK; Shin YO; Shin SC; Lee YH; Hwang HM; Lim MR
    Psychiatr Genet; 2001 Sep; 11(3):111-4. PubMed ID: 11702051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin 2A receptor gene polymorphism is not associated with completed suicide.
    Ono H; Shirakawa O; Nishiguchi N; Nishimura A; Nushida H; Ueno Y; Maeda K
    J Psychiatr Res; 2001; 35(3):173-6. PubMed ID: 11461713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes].
    Sugie Y; Sugie H; Fukuda T; Ito M; Ohzeki T
    No To Hattatsu; 2003 May; 35(3):233-7. PubMed ID: 12755054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.
    Yoshida K; Naito S; Takahashi H; Sato K; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1279-83. PubMed ID: 12502014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.